Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments

Detalles Bibliográficos
Autores principales: Peng, Ge, Okumura, Ko, Ogawa, Hideoki, Ikeda, Shigaku, Niyonsaba, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800418/
https://www.ncbi.nlm.nih.gov/pubmed/35104583
http://dx.doi.org/10.1016/j.jaad.2022.01.041
_version_ 1784642256084402176
author Peng, Ge
Okumura, Ko
Ogawa, Hideoki
Ikeda, Shigaku
Niyonsaba, François
author_facet Peng, Ge
Okumura, Ko
Ogawa, Hideoki
Ikeda, Shigaku
Niyonsaba, François
author_sort Peng, Ge
collection PubMed
description
format Online
Article
Text
id pubmed-8800418
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-88004182022-01-31 Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments Peng, Ge Okumura, Ko Ogawa, Hideoki Ikeda, Shigaku Niyonsaba, François J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2022-09 2022-01-29 /pmc/articles/PMC8800418/ /pubmed/35104583 http://dx.doi.org/10.1016/j.jaad.2022.01.041 Text en © 2022 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Peng, Ge
Okumura, Ko
Ogawa, Hideoki
Ikeda, Shigaku
Niyonsaba, François
Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments
title Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments
title_full Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments
title_fullStr Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments
title_full_unstemmed Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments
title_short Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments
title_sort psoriatic lesional expression of sars-cov-2 receptor ace2 is reduced by blockade of il-17 signaling but not by other biologic treatments
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800418/
https://www.ncbi.nlm.nih.gov/pubmed/35104583
http://dx.doi.org/10.1016/j.jaad.2022.01.041
work_keys_str_mv AT pengge psoriaticlesionalexpressionofsarscov2receptorace2isreducedbyblockadeofil17signalingbutnotbyotherbiologictreatments
AT okumurako psoriaticlesionalexpressionofsarscov2receptorace2isreducedbyblockadeofil17signalingbutnotbyotherbiologictreatments
AT ogawahideoki psoriaticlesionalexpressionofsarscov2receptorace2isreducedbyblockadeofil17signalingbutnotbyotherbiologictreatments
AT ikedashigaku psoriaticlesionalexpressionofsarscov2receptorace2isreducedbyblockadeofil17signalingbutnotbyotherbiologictreatments
AT niyonsabafrancois psoriaticlesionalexpressionofsarscov2receptorace2isreducedbyblockadeofil17signalingbutnotbyotherbiologictreatments

Ejemplares similares